Haemopoiesis Flashcards

1
Q

Describe the locations of Haemopoesis throughout life

A

Foetus: yolk sac, liver/spleen then bone marrow
Infant: bone marrow of all bones
Adult: bone marrow in axial skeleton and end of femur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the hierarchy of Haemopoiesis

A

Begins with a single unspecialised pluripotent stem cell which is capable of self-renewal or can become myeloid or lymphoid stem cell, which can then differentiate further into a functional cell. They can also undergo apoptosis as another fate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the different types of HSC division

A

Symmetrical or asymmetrical. Symmetrical produces 1 stem cell and 1 differentiating cell. Asymmetrical division produces either 2 stem cells or 2 differentiating cells (contraction/expansion of stem cell numbers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What controls the balance of HSC division?

A

Environmental factors and internal cues from the cell itself (selected embryonic patterning pathways - Wnt, Notch, SHH etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the stromal cells of the bone marrow

A
  • macrophages
  • fibroblasts
  • endothelial cells
  • fat cells
  • reticulum cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is leukamogenesis?

A

When a HSC/early myeloid/lymphoid cell undergoes a leukomogenic event (genetic mutation) resulting in clonogenic leukaemia cells (capable of dysregulated growth and differentiation). Proliferation of this clone occurs with differentiation blocked at an early stage resulting in a large number of immature and non-functional cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe myeloproliferative disorders

A

Clonal disorders which result in increased numbers of one or more mature blood progeny. Associated with JAK2 and calreticulin mutations. Possibility of becoming AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is an example of a myeloproliferative disorder?

A

JAK2 positive ET
- essential thrombocythaemia (bone marrow produces too many platelets) causing aggregation and increased risk of clots
- mutation of JAK2 (responsible for making protein that controls how many blood cells the stem cells make)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe myelodyspplastic syndromes

A

Disorders resulting in dysplasia and ineffective Haemopoiesis in 1 or more of the blood cells of the bone marrow.
- can be caused by previous chemotherapy/radiotherapy or acquired cytogenetic abnormalities
- may have increased levels of myoblasts
- characterised by progressive bone marrow failure
- some progress to AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is an example of a myelodysplastic syndrome?

A

Fanconi anaemia (AR inheritance):
- causes aplastic anaemia in a minority of cases
- causes somatic abnormalities, bone marrow failure, short telomeres, malignancy and chromosomal instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical effects of Fanconi anaemia?

A
  • microphthlamia
  • GU malformations
  • GI malformations
  • mental retardation
  • hearing loss
  • CNS problems (eg. Hydrocephalus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the genetic mechanism associated with Fanconi anaemia progression to cancer

A
  • mutation occurs resulting in altered DNA damage response causing damaged cells to continue to be produced, an abnormal stress response, and the ups regulation of MAPKs
  • MAPKs lead to the upregulation of TNF-alpha (inflammatory factor), which along with an abnormal oxidative stress response and environmental factors (which can increase risk of cancer) lead to genomic instability
  • leading to the production of an FA cancer cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the types of stem cell transplant and their indications?

A
  • autologous: patient uses own blood stem cells (indicated in relapsed HL/NHL and myelomas)
  • Allogeneic: stem cells come from donor (indicated in AML/CML/aplastic anaemia/hereditary disorders)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the types of stem cell donor?

A
  • syngeneic: between twins
  • Allogeneic: HLA match identical from sibling
  • haplotype: a half matched family member
  • umbilical cord
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the process of autologous stem cell transplant

A
  • patient receives growth factor with or without chemo to make stem cells leave the bone marrow for collection
    -mobilised peripheral blood stem cells are harvested by apheresis (blood is passed through an apparatus which separates out the stem cell sample and returns the remainder of the blood back into circulation)
  • Mozobil can be used alternatively to collect stem cells in patients who fail to mobilise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the process of umbilical cord stem cell transplant

A
  • stem cells are collected from umbilical cord and placenta
  • sample is tissue types (tested for compatibility type) and frozen in liquid nitrogen and stored in blood banks for future use
17
Q

What are the benefits and disadvantages of umbilical cord stem cell transplants?

A

Advantages:
- more rapidly available than VUD
- less vigorous matching to patient HLA as the immune system of the cord blood is naive

Disadvantages:
- small amount of individuals will require double transplant
- slower engraftment
- if replace occurs, patient cannot go back to donor lymphocyte infusion

18
Q

What is a main benefit of Allogeneic stem cell transplants particularly in leukaemia

A

The graft has a graft vs leukaemia effect (but can also have GVHD)

19
Q

Describe the process of myeloablative regimens of Allogeneic stem cell transplant

A
  • patient is conditions with radiotherapy and high dose chemotherapy before receiving the bone marrow transplant resulting in complete replacement of blood cells with donor type
  • can result in a blood type change and if a female patient is receiving a bone marrow transplant from a male then the blood may have presence of Y chromosomes
20
Q

Describe the mini-transplant regimen of Allogeneic stem cell transplant

A
  • patient is conditioned with lower intensity radiotherapy and low dose chemotherapy before receiving the bone marrow transplant
  • patient becomes a mixed chimera where blood is a mix of theirs and donor’s cells
  • a donor lymphocyte infusion is given to replace all blood cells with donor cells
  • in event of relapse of patient reverting back to mixed chimera, DLI are give again in gradually increasing concentrations to convert back to donor cells fully
21
Q

What are the disadvantages of stem cell transplants?

A
  • limited donor availability
  • mortality 10-50% (depending on risk factors)
  • GVHD
  • immunosuppression
  • risk of infertility
  • effects of TBI = hypothyroidism, dry eyes and mouth, cataracts, secondary malignancy, osteoporosis
  • relapse